Cargando…
A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19
OBJECTIVE: To assess the effect of linagliptin vs. standard therapy in improving clinical outcomes in patients hospitalized with diabetes and coronavirus disease 2019 (COVID-19). MATERIALS AND METHODS: We did an open-label, prospective, multicenter, randomized clinical trial in 3 Israeli hospitals b...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727772/ https://www.ncbi.nlm.nih.gov/pubmed/35002970 http://dx.doi.org/10.3389/fendo.2021.794382 |